Related Experiment Video
Updated: Jul 15, 2026
06:02
Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025
GFAP and its role in Alexander disease
Roy A Quinlan1, Michael Brenner, James E Goldman
1School of Biological and Biomedical Sciences, The University, Durham DH1 3LE, UK. r.a.quinlan@durham.ac.uk
Experimental Cell Research
|May 15, 2007
Summary
GFAP mutations trigger Alexander disease through GFAP aggregate formation, chaperone sequestration, and stress pathway activation. These events collectively lead to this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Alexander disease is a rare, fatal neurological disorder.
- It is characterized by the accumulation of glial fibrillary acidic protein (GFAP) aggregates.
- GFAP mutations are the primary genetic cause of Alexander disease.
Purpose of the Study:
- To review the molecular mechanisms by which GFAP mutations cause Alexander disease.
- To discuss parallels with other intermediate filament diseases.
- To explore potential therapies and diagnostic trends for Alexander disease.
Main Methods:
- Review of existing scientific literature on GFAP mutations and Alexander disease.
- Analysis of cellular events leading to disease pathogenesis.
- Comparison with other intermediate filament proteinopathies.
Main Results:
- GFAP mutations lead to GFAP accumulation and Rosenthal fiber formation.
- Rosenthal fibers sequester alpha B-crystallin and HSP27 chaperones.
- Jnk pathway and stress responses are activated, contributing to Alexander disease.
Conclusions:
- A combination of GFAP aggregation, chaperone sequestration, and stress pathway activation drives Alexander disease.
- Understanding these mechanisms is crucial for developing targeted therapies.
- Further research into GFAP and intermediate filament diseases is ongoing.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...